TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 2 | 1 | 1 | 21 | 67 | 62 | 30 | 30 |
P | %wins | 50 | 50 | 100 | 100 | 100 | 50 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/18/17 16:17 | 10/17/17 | GNMX | Aevi Genomic Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Clemow Alastair J | PA | D | P.d | 25 | 1.26 | 0 | 20 | 53 | 58 | D | |||||||||||||||
12/2/14 08:48 | 12/1/14 | MDGN | Medgenics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Clemow Alastair J T | PA | D | P | 50 | 4.10 | 0 | 12 | 48 | 38 | D | -49 | -35 | -43 | -31 | -14 | -19 | -11 | 0 | -2 | -6 | 19 | 90 | 82 | 62 | |
12/18/13 08:31 | 12/16/13 | MDGN | Medgenics, Inc. | NY | Health | BioPrd | Biological Products, (No Diag | Clemow Alastair J T | PA | D | P | 26 | 5.78 | 0 | 5 | 32 | 19 | D | 98 | -31 | 45 | 3 | -19 | -13 | -16 | -8 | 3 | 8 | 22 | 44 | 42 | -3 | |
11/3/06 16:03 | 11/3/06 | ENMC | Encore Medical Corp | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Clemow Alastair J T | NJ | D | M.d | 206 | 4.57 | 0 | 45 | 30 | D | ||||||||||||||||
11/3/06 16:03 | 11/3/06 | ENMC | Encore Medical Corp | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Clemow Alastair J T | NJ | D | S.d | -295 | 6.55 | 0 | -45 | -60 | 30 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |